Sale disclosed
David Kirn
See Remarks
Common Stock
- Reported value
- $750.24K
- Reported price
- $12.9215 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
4D Molecular Therapeutics, Inc.
Last 30 daysNo qualifying insider buying. Sales: $1.59M by 2 insiders.
Showing the first 6 of 44 trades on this page.
See Remarks
Common Stock
See Remarks
Common Stock
Chief Legal Officer
Common Stock
Chief Legal Officer
Common Stock
Chief Legal Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
See Remarks
Common Stock
Chief Legal Officer
Common Stock
Chief Legal Officer
Common Stock
Chief Legal Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
See Remarks
Common Stock
See Remarks
Common Stock
See Remarks
Common Stock
See Remarks
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Legal Officer
Common Stock
Chief Legal Officer
Common Stock
Chief Legal Officer
Common Stock
Chief Legal Officer
Common Stock
Chief Legal Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Legal Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
See Remarks
Common Stock
See Remarks
Common Stock
See Remarks
Common Stock
See Remarks
Common Stock
See Remarks
Common Stock
Chief Legal Officer
Common Stock
Chief Legal Officer
Common Stock
Chief Legal Officer
Common Stock
Chief Legal Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Legal Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Legal Officer
Common Stock
Chief Legal Officer
Common Stock
Chief Legal Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
See Remarks
Common Stock
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
See Remarks
Common Stock
Chief Executive Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Legal Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
See Remarks
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| See Remarks | Common StockSale10b5-12 trades | 58,333avg $12.92 / share | $753.94K | Oct 5Filed Oct 7 · 2d later | 2 filings
|
| Chief Legal Officer | Common StockOption exercise or conversion10b5-1 | 1,635$4.14 / share | $6.77K | Sep 16Filed Sep 22 · 6d later | SEC filing |
| Chief Legal Officer | Common StockSale10b5-1 | 1,635$13.65 / share | $22.32K | Sep 16Filed Sep 22 · 6d later | SEC filing |
| Chief Legal Officer | Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units1,635$4.14 exercise / conversion price | Not a separate purchase | Sep 16Filed Sep 22 · 6d later | SEC filing |
| See Remarks | Common StockSale10b5-1 | 58,333$13.90 / share | $811K | Sep 14Filed Sep 16 · 2d later | SEC filing |
| Chief Legal Officer | Common StockOption exercise or conversion10b5-1 | 584$6.49 / share | $3.79K | Sep 1Filed Sep 3 · 2d later | SEC filing |
| Chief Legal Officer | Common StockSale10b5-1 | 584$14.00 / share | $8.18K | Sep 1Filed Sep 3 · 2d later | SEC filing |
| Chief Legal Officer | Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units584$6.49 exercise / conversion price | Not a separate purchase | Sep 1Filed Sep 3 · 2d later | SEC filing |
| See Remarks | Common StockOption exercise or conversion10b5-1 | 50,000$4.14 / share | $207K | Aug 19Filed Aug 21 · 2d later | SEC filing |
| See Remarks | Common StockSale10b5-12 trades | 69,076avg $15.75 / share | $1.09M | Aug 19Filed Aug 21 · 2d later | 2 filings
|
| See Remarks | Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units50,000$4.14 exercise / conversion price | Not a separate purchase | Aug 19Filed Aug 21 · 2d later | SEC filing |
| Chief Legal Officer | Common StockOption exercise or conversion10b5-1 | 1,635$4.14 / share | $6.77K | Aug 13Filed Aug 17 · 4d later | SEC filing |
| Chief Legal Officer | Common StockSale10b5-1 | 1,635$12.00 / share | $19.62K | Aug 13Filed Aug 17 · 4d later | SEC filing |
| Chief Legal Officer | Common StockOption exercise or conversion10b5-1 | 1,635$4.14 / share | $6.77K | Aug 17Filed Aug 17 · 0d later | SEC filing |
| Chief Legal Officer | Common StockSale10b5-1 | 1,635$12.20 / share | $19.95K | Aug 17Filed Aug 17 · 0d later | SEC filing |
| Chief Legal Officer | Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units1,635$4.14 exercise / conversion price | Not a separate purchase | Aug 13Filed Aug 17 · 4d later | SEC filing |
| Chief Legal Officer | Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units1,635$4.14 exercise / conversion price | Not a separate purchase | Aug 17Filed Aug 17 · 0d later | SEC filing |
| See Remarks | Common StockSale10b5-1 | 26,842$10.23 / share | $274.6K | Aug 4Filed Aug 5 · 1d later | SEC filing |
| See Remarks | Common StockSale10b5-1 | 12,415$10.05 / share | $124.72K | Aug 3Filed Aug 4 · 1d later | SEC filing |
| See Remarks | Common StockSale10b5-1 | 42,608$12.87 / share | $548.18K | Jul 9Filed Jul 14 · 5d later | SEC filing |
| See Remarks | Common StockSale10b5-12 trades | 15,725avg $12.03 / share | $189.23K | Jul 10Filed Jul 14 · 4d later | 2 filings
|
| Chief Legal Officer | Common StockOption exercise or conversion10b5-1 | 814$4.14 / share | $3.37K | Jun 30Filed Jul 2 · 2d later | SEC filing |
| Chief Legal Officer | Common StockOption exercise or conversion10b5-1 | 5,752$6.49 / share | $37.33K | Jun 30Filed Jul 2 · 2d later | SEC filing |
| Chief Legal Officer | Common StockSale10b5-1 | 6,566$14.00 / share | $91.92K | Jun 30Filed Jul 2 · 2d later | SEC filing |
| Chief Legal Officer | Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units814$4.14 exercise / conversion price | Not a separate purchase | Jun 30Filed Jul 2 · 2d later | SEC filing |
| Chief Legal Officer | Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units5,752$6.49 exercise / conversion price | Not a separate purchase | Jun 30Filed Jul 2 · 2d later | SEC filing |
| Chief Legal Officer | Common StockOption exercise or conversion10b5-1 | 9,810$4.14 / share | $40.61K | Jun 23Filed Jun 25 · 2d later | SEC filing |
| Chief Legal Officer | Common StockSale10b5-1 | 9,810$12.00 / share | $117.72K | Jun 23Filed Jun 25 · 2d later | SEC filing |
| Chief Legal Officer | Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units9,810$4.14 exercise / conversion price | Not a separate purchase | Jun 23Filed Jun 25 · 2d later | SEC filing |
| See Remarks | Common StockSale10b5-1 | 114,746$10.47 / share | $1.2M | Jun 22Filed Jun 23 · 1d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units50,000Award · no purchase price | Non-cash award | Jun 17Filed Jun 18 · 1d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units50,000Award · no purchase price | Non-cash award | Jun 17Filed Jun 18 · 1d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units50,000Award · no purchase price | Non-cash award | Jun 17Filed Jun 18 · 1d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units50,000Award · no purchase price | Non-cash award | Jun 17Filed Jun 18 · 1d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units75,000Award · no purchase price | Non-cash award | Jun 17Filed Jun 18 · 1d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units50,000Award · no purchase price | Non-cash award | Jun 17Filed Jun 18 · 1d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units50,000Award · no purchase price | Non-cash award | Jun 17Filed Jun 18 · 1d later | SEC filing |
| See Remarks | Common StockSale10b5-1 | 1,922$10.02 / share | $19.26K | Jun 1Filed Jun 2 · 1d later | SEC filing |
| Chief Executive Officer | Stock Option (Right to Buy)Grant or award | Derivative units750,000Award · no purchase price | Non-cash award | Mar 25Filed Mar 27 · 2d later | SEC filing |
| Chief Legal Officer | Stock Option (Right to Buy)Grant or award | Derivative units217,000Award · no purchase price | Non-cash award | Mar 25Filed Mar 27 · 2d later | SEC filing |
| See Remarks | Stock Option (Right to Buy)Grant or award | Derivative units219,000Award · no purchase price | Non-cash award | Mar 25Filed Mar 27 · 2d later | SEC filing |
This reflects the filings imported so far, not a complete trading history.
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.